Company presentations are the cornerstone of the annual J.P. Morgan Healthcare Conference, but one of the most well-attended talks at this year's meeting was delivered by Kimberly Powell, vice president and general manager of health care at NVIDIA. Given that what happens at JPM is a reliable indicator of things to come, this year is set to be the year big tech takes a prominent seat at the biopharma table.
Powell made two industry-related announcements. First, she said AI-driven drug biotech Recursion Pharmaceuticals, Inc., into which NVIDIA has invested...